Smoking predisposes to parotid adenolymphoma

Area of Science:

• Oncology
• Epidemiology
• Pathology

Background:

• Parotid lumps are common, with pleomorphic adenomas and adenolymphomas being frequent benign diagnoses.
• Understanding risk factors for these tumors is crucial for early detection and management.
• Previous studies have explored various associations, but the role of smoking and blood groups requires further investigation.

Purpose of the Study:

• To investigate the association between ABO blood groups and smoking habits in patients diagnosed with pleomorphic adenoma or adenolymphoma.
• To compare the prevalence of specific ABO blood groups and smoking patterns in these two parotid tumor types.

Main Methods:

• Retrospective analysis of 574 patients with untreated parotid lumps.
• Histological confirmation of 194 pleomorphic adenomas and 73 adenolymphomas.
• Collection and analysis of ABO blood group and smoking data, compared against standard population sources.

Main Results:

• No significant association was found between either pleomorphic adenoma or adenolymphoma and abnormal ABO blood group patterns.
• A significantly higher incidence of smoking was observed in patients with adenolymphoma compared to those with pleomorphic adenoma.
• Patients with adenolymphoma had smoked a mean of 300,000 cigarettes, versus 80,000 for pleomorphic adenoma patients; only 1/63 adenolymphoma patients had never smoked compared to 31/75 pleomorphic adenoma patients.

Conclusions:

• ABO blood groups do not appear to be a risk factor for developing pleomorphic adenoma or adenolymphoma.
• Smoking is strongly associated with adenolymphoma, suggesting it may be a significant risk factor for this specific parotid tumor type.